KR20190100205A - 당뇨성 말초 신경병증 치료용 물품 - Google Patents

당뇨성 말초 신경병증 치료용 물품 Download PDF

Info

Publication number: KR20190100205A
Authority: KR; South Korea
Prior art keywords: article; peripheral neuropathy; tissue; target; electrical stimulation
Prior art date: 2016-12-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

KR1020197018171A

Other languages

English (en)

Korean (ko)

Inventor

제레미 디 올레렌쇼

레아 엠 롤던

엘리엇 비 부르주아

에릭 에이 셰피스

Original Assignee

아벤트, 인크.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-12-27

Filing date

2017-12-08

Publication date

2019-08-28

2017-12-08 Application filed by 아벤트, 인크. filed Critical 아벤트, 인크.

2019-08-28 Publication of KR20190100205A publication Critical patent/KR20190100205A/ko

Status Withdrawn legal-status Critical Current

Links

208000032131 Diabetic Neuropathies Diseases 0.000 title claims description 30
230000000638 stimulation Effects 0.000 claims abstract description 98
210000001519 tissue Anatomy 0.000 claims abstract description 63
238000000034 method Methods 0.000 claims abstract description 54
210000000944 nerve tissue Anatomy 0.000 claims abstract description 52
208000033808 peripheral neuropathy Diseases 0.000 claims abstract description 47
230000002792 vascular Effects 0.000 claims abstract description 34
230000001537 neural effect Effects 0.000 claims abstract description 21
230000024883 vasodilation Effects 0.000 claims abstract description 16
208000002193 Pain Diseases 0.000 claims description 23
239000000463 material Substances 0.000 claims description 22
210000004204 blood vessel Anatomy 0.000 claims description 11
230000005684 electric field Effects 0.000 claims description 11
210000000578 peripheral nerve Anatomy 0.000 claims description 11
206010040030 Sensory loss Diseases 0.000 claims description 9
210000005036 nerve Anatomy 0.000 claims description 8
210000005166 vasculature Anatomy 0.000 claims description 8
230000010412 perfusion Effects 0.000 claims description 5
239000012778 molding material Substances 0.000 claims description 4
238000011084 recovery Methods 0.000 claims description 3
210000002683 foot Anatomy 0.000 description 23
210000003371 toe Anatomy 0.000 description 20
239000012530 fluid Substances 0.000 description 13
230000017531 blood circulation Effects 0.000 description 11
206010012601 diabetes mellitus Diseases 0.000 description 11
239000004744 fabric Substances 0.000 description 7
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
210000001367 artery Anatomy 0.000 description 6
230000008081 blood perfusion Effects 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
239000000499 gel Substances 0.000 description 6
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
229910052799 carbon Inorganic materials 0.000 description 5
208000035824 paresthesia Diseases 0.000 description 5
230000035807 sensation Effects 0.000 description 5
230000001953 sensory effect Effects 0.000 description 5
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
238000000576 coating method Methods 0.000 description 4
238000004891 communication Methods 0.000 description 4
239000004020 conductor Substances 0.000 description 4
239000003814 drug Substances 0.000 description 4
229940079593 drug Drugs 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
239000002184 metal Substances 0.000 description 4
230000002093 peripheral effect Effects 0.000 description 4
229920002120 photoresistant polymer Polymers 0.000 description 4
208000000094 Chronic Pain Diseases 0.000 description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
238000005229 chemical vapour deposition Methods 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
229910052709 silver Inorganic materials 0.000 description 3
239000004332 silver Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 2
102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 2
244000025254 Cannabis sativa Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
206010049567 Miller Fisher syndrome Diseases 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
241000220010 Rhode Species 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
230000003444 anaesthetic effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
230000036770 blood supply Effects 0.000 description 2
208000003295 carpal tunnel syndrome Diseases 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000000151 deposition Methods 0.000 description 2
238000013461 design Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
229920001971 elastomer Polymers 0.000 description 2
239000000806 elastomer Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
-1 etc.) Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000000976 ink Substances 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
239000007788 liquid Substances 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000007383 nerve stimulation Effects 0.000 description 2
201000001119 neuropathy Diseases 0.000 description 2
230000007823 neuropathy Effects 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000004544 sputter deposition Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
229940124549 vasodilator Drugs 0.000 description 2
239000003071 vasodilator agent Substances 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
208000003808 Amyloid Neuropathies Diseases 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
208000000412 Avitaminosis Diseases 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
208000017899 Foot injury Diseases 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
208000011092 Hand injury Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000027747 Kennedy disease Diseases 0.000 description 1
208000034693 Laceration Diseases 0.000 description 1
206010024229 Leprosy Diseases 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
206010029174 Nerve compression Diseases 0.000 description 1
208000028389 Nerve injury Diseases 0.000 description 1
241000208125 Nicotiana Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000005374 Poisoning Diseases 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
229910021607 Silver chloride Inorganic materials 0.000 description 1
208000001163 Tangier disease Diseases 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
208000007642 Vitamin B Deficiency Diseases 0.000 description 1
206010047627 Vitamin deficiencies Diseases 0.000 description 1
208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000002266 amputation Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000012984 antibiotic solution Substances 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
239000010425 asbestos Substances 0.000 description 1
239000005441 aurora Substances 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000005465 channeling Effects 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
229920001940 conductive polymer Polymers 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
238000013481 data capture Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000008482 dysregulation Effects 0.000 description 1
230000005611 electricity Effects 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000002357 endometrial effect Effects 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000010408 film Substances 0.000 description 1
210000003811 finger Anatomy 0.000 description 1
229910003472 fullerene Inorganic materials 0.000 description 1
229910021397 glassy carbon Inorganic materials 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
239000010439 graphite Substances 0.000 description 1
210000004247 hand Anatomy 0.000 description 1
208000003532 hypothyroidism Diseases 0.000 description 1
230000002989 hypothyroidism Effects 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000011810 insulating material Substances 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000037427 ion transport Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000008720 membrane thickening Effects 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910001092 metal group alloy Inorganic materials 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
210000001872 metatarsal bone Anatomy 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
229910021392 nanocarbon Inorganic materials 0.000 description 1
230000008764 nerve damage Effects 0.000 description 1
230000006764 neuronal dysfunction Effects 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
239000012811 non-conductive material Substances 0.000 description 1
231100000862 numbness Toxicity 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229940005483 opioid analgesics Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
208000027232 peripheral nervous system disease Diseases 0.000 description 1
238000005240 physical vapour deposition Methods 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
229920005596 polymer binder Polymers 0.000 description 1
239000002491 polymer binding agent Substances 0.000 description 1
238000007639 printing Methods 0.000 description 1
239000002964 rayon Substances 0.000 description 1
238000005546 reactive sputtering Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
229910052895 riebeckite Inorganic materials 0.000 description 1
238000007650 screen-printing Methods 0.000 description 1
210000002265 sensory receptor cell Anatomy 0.000 description 1
102000027509 sensory receptors Human genes 0.000 description 1
108091008691 sensory receptors Proteins 0.000 description 1
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000010409 thin film Substances 0.000 description 1
206010048627 thoracic outlet syndrome Diseases 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
239000010936 titanium Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
229940100640 transdermal system Drugs 0.000 description 1
238000012546 transfer Methods 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
208000036722 ulnar neuropathy Diseases 0.000 description 1
230000004855 vascular circulation Effects 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
210000002268 wool Anatomy 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36153—Voltage
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36157—Current
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36171—Frequency
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Radiology & Medical Imaging (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Electrotherapy Devices (AREA)

KR1020197018171A 2016-12-27 2017-12-08 당뇨성 말초 신경병증 치료용 물품 Withdrawn KR20190100205A (ko)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201662439283P	2016-12-27	2016-12-27
US62/439,283		2016-12-27
PCT/US2017/065243 WO2018125538A1 (en)	2016-12-27	2017-12-08	Article for treating diabetic peripheral neuropathy

Publications (1)

Publication Number	Publication Date
KR20190100205A true KR20190100205A (ko)	2019-08-28

Family

ID=60888650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020197018171A Withdrawn KR20190100205A (ko)	2016-12-27	2017-12-08	당뇨성 말초 신경병증 치료용 물품

Country Status (7)

Country	Link
US (2)	US11471677B2 (2)
EP (1)	EP3562541B1 (2)
JP (1)	JP2020503111A (2)
KR (1)	KR20190100205A (2)
AU (1)	AU2017387791B2 (2)
MX (1)	MX2019007714A (2)
WO (1)	WO2018125538A1 (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023191236A1 (ko) *	2022-03-30	2023-10-05	(주)웨이브트리	손 또는 발 부위의 말초신경 자극장치

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9833614B1 (en)	2012-06-22	2017-12-05	Nevro Corp.	Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US12453853B2 (en)	2013-01-21	2025-10-28	Cala Health, Inc.	Multi-modal stimulation for treating tremor
AU2014207265B2 (en)	2013-01-21	2017-04-20	Cala Health, Inc.	Devices and methods for controlling tremor
AU2015271774B2 (en)	2014-06-02	2020-04-16	Cala Health, Inc.	Systems and methods for peripheral nerve stimulation to treat tremor
EP4342516A3 (en)	2015-06-10	2024-07-10	Cala Health, Inc.	Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units
US10695575B1 (en)	2016-05-10	2020-06-30	Btl Medical Technologies S.R.O.	Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en)	2016-07-01	2018-01-04	Btl Holdings Limited	Aesthetic method of biological structure treatment by magnetic field
EP3328277A4 (en)	2015-07-31	2019-03-06	Cala Health, Inc.	SYSTEMS, DEVICES AND METHOD FOR TREATING OSTEOARTHRITIS
US10603482B2 (en)	2015-09-23	2020-03-31	Cala Health, Inc.	Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
AU2017211048B2 (en)	2016-01-21	2022-03-10	Cala Health, Inc.	Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
US11464993B2 (en)	2016-05-03	2022-10-11	Btl Healthcare Technologies A.S.	Device including RF source of energy and vacuum system
JP7133543B2 (ja)	2016-08-25	2022-09-08	カラヘルス，インコーポレイテッド	末梢神経刺激による心機能不全の治療のためのシステムおよび方法
US20180272132A1 (en)	2017-01-19	2018-09-27	Nevro Corp.	High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods
US11331480B2 (en)	2017-04-03	2022-05-17	Cala Health, Inc.	Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
WO2019143790A1 (en)	2018-01-17	2019-07-25	Cala Health, Inc.	Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
FR3092496B1 (fr)	2018-12-07	2025-05-30	Avent Inc	Dispositif et procede pour moduler de maniere selective et reversible une structure du systeme nerveux afin d’inhiber la douleur
US12558146B2 (en)	2019-04-11	2026-02-24	Btl Medical Solutions A.S.	Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US12251560B1 (en)	2019-08-13	2025-03-18	Cala Health, Inc.	Connection quality determination for wearable neurostimulation systems
US11890468B1 (en)	2019-10-03	2024-02-06	Cala Health, Inc.	Neurostimulation systems with event pattern detection and classification
US20210121682A1 (en) *	2019-10-27	2021-04-29	Texas Woman's University	Sock that wirelessly delivers electrical signals directly to the foot and ankle muscles for the treatment of pain
JP2023515722A (ja)	2020-05-04	2023-04-13	ビーティーエルヘルスケアテクノロジーズエー．エス．	患者の非アテンド式治療のためのデバイスおよび方法
US11878167B2 (en)	2020-05-04	2024-01-23	Btl Healthcare Technologies A.S.	Device and method for unattended treatment of a patient
US12611545B2 (en)	2020-05-04	2026-04-28	Btl Healthcare Technologies A.S.	Device and method for unattended treatment of a patient
US12350490B2 (en) *	2022-05-04	2025-07-08	Neurological Fitness Equipment and Education LLC	Electrotherapy glove for delivery of amplitude modulated pulsed direct current during manual therapy treatment
GB2619011A (en) *	2022-05-19	2023-11-29	Guys And St Thomas Nhs Found Trust	Apparatus and method for causing vasoconstriction by electrical stimulation
EP4547322A1 (en)	2022-07-01	2025-05-07	Nevro Corporation	Neurostimulation for treating sensory deficits, and associated systems and methods
US12491363B2 (en)	2023-03-24	2025-12-09	Taiwan Resonant Waves Research Corp.	Electrical stimulation system and a method thereof
AU2023201838B2 (en) *	2023-03-24	2024-11-21	Taiwan Resonant Waves Research Corp.	Electrical stimulation system and a method thereof
EP4727638A1 (en) *	2023-05-09	2026-04-22	Nevro Corp.	Long pulse width spinal cord stimulation for treating diabetic neuropathy, and associated systems and methods
US20250018173A1 (en) *	2023-07-10	2025-01-16	Steve O'neal	Sensory Control System
US20250099746A1 (en) *	2023-08-18	2025-03-27	Stimmed Llc	Method and apparatus for noninvasive inhibition of deep vein thrombosis
US20260097226A1 (en)	2024-10-08	2026-04-09	Btl Medical Solutions A.S.	Devices and methods for application of a magnetic field to the nervous system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4521365A (en)	1983-12-20	1985-06-04	Bio Research Inc.	Glove molding apparatus and method
US5693401A (en)	1996-05-01	1997-12-02	Kimberly-Clark Worldwide, Inc.	Surgical glove retainer
US7013179B2 (en) *	2000-01-07	2006-03-14	Biowave Corporation	Percutaneous electrode array
KR100797144B1 (ko)	2001-06-01	2008-01-22	아이-플로우 코포레이션	대용량 볼러스 장치 및 방법
US20040039417A1 (en)	2002-04-16	2004-02-26	Medtronic, Inc.	Electrical stimulation and thrombolytic therapy
US6745078B1 (en) *	2002-04-24	2004-06-01	Kelly W. Buchner	Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence
JP2006521879A (ja) *	2003-03-06	2006-09-28	アフェレントコーポレイション	人間の平衡及び歩行の改善並びに足の傷害の防止のための方法及び装具
CA2530396C (en) *	2003-06-24	2015-03-24	Healthonics, Inc.	Apparatus and method for bioelectric stimulation, healing acceleration, pain relief, or pathegen devitalization
JP4057558B2 (ja) *	2004-06-09	2008-03-05	伊藤超短波株式会社	筋肉トレーニング装置
CN101600471B (zh)	2004-10-05	2012-11-07	阿迪安公司	肾神经调节的方法和装置
US7542804B2 (en) *	2004-12-03	2009-06-02	Alfred E. Mann Foundation For Scientific Research	Neuromuscular stimulation to avoid pulmonary embolisms
US9339641B2 (en) *	2006-01-17	2016-05-17	Emkinetics, Inc.	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US20090312676A1 (en) *	2006-02-02	2009-12-17	Tylerton International Inc.	Metabolic Sink
EP1981584B1 (en) *	2006-02-03	2015-05-13	Interventional Autonomics Corporation	Intravascular device for neuromodulation
ES2664415T3 (es) *	2006-07-05	2018-04-19	Precisis Ag	Sistema para el tratamiento de trastornos neurológicos mediante estimulación eléctrica
US20080195176A1 (en)	2007-02-12	2008-08-14	The Research Foundation Of State University Of New York	Raynaud's Conditions
AU2010275413A1 (en) *	2009-07-23	2012-02-09	Emkinetics, Inc.	Method and apparatus for magnetic induction therapy
KR100994208B1 (ko) *	2009-07-28	2010-11-12	이지훈	미세전류 자극용 양말
AU2011350896A1 (en) *	2010-12-30	2013-05-02	The Hospital For Sick Children	Methods and devices relating to non-invasive electrical nerve stimulation
US9271864B2 (en) *	2011-10-04	2016-03-01	Feinstein Patents Llc	Orthosis for range of motion, muscular and neurologic rehabilitation of the lower extremities
US10092750B2 (en)	2011-11-11	2018-10-09	Neuroenabling Technologies, Inc.	Transcutaneous neuromodulation system and methods of using same
US8958886B2 (en) *	2012-12-31	2015-02-17	Kimberly-Clark Worldwide, Inc.	Method and apparatus to increase tactile senstivity and proprioception in humans
JPWO2014136852A1 (ja) *	2013-03-06	2017-02-16	学校法人久留米大学	電気刺激装置
WO2014164438A1 (en)	2013-03-11	2014-10-09	Ohio State Innovation Foundation	Devices and systems for treating obstetric and gynecological disorders
EP2968910A4 (en) *	2013-03-15	2016-11-02	Emkinetics Inc	METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES
GB2531619A (en) *	2014-09-12	2016-04-27	Innovarius Ltd	Apparatus and method for providing hyperthermia therapy
US10478612B2 (en) *	2014-10-31	2019-11-19	Avent, Inc.	Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation
US10080884B2 (en) *	2014-12-29	2018-09-25	Ethicon Llc	Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) *	2014-12-29	2018-10-09	Ethicon Llc	Methods and devices for inhibiting nerves when activating brown adipose tissue
CN108778403B (zh) *	2015-12-22	2022-09-13	明尼苏达大学董事会	提供交感神经调制治疗的系统

2017
- 2017-12-08 EP EP17822881.3A patent/EP3562541B1/en active Active
- 2017-12-08 MX MX2019007714A patent/MX2019007714A/es unknown
- 2017-12-08 JP JP2019534277A patent/JP2020503111A/ja active Pending
- 2017-12-08 US US16/469,182 patent/US11471677B2/en active Active
- 2017-12-08 KR KR1020197018171A patent/KR20190100205A/ko not_active Withdrawn
- 2017-12-08 AU AU2017387791A patent/AU2017387791B2/en not_active Ceased
- 2017-12-08 WO PCT/US2017/065243 patent/WO2018125538A1/en not_active Ceased
2022
- 2022-09-09 US US17/930,787 patent/US20230001202A1/en not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2023191236A1 (ko) *	2022-03-30	2023-10-05	(주)웨이브트리	손 또는 발 부위의 말초신경 자극장치

Also Published As

Publication number	Publication date
US20230001202A1 (en)	2023-01-05
JP2020503111A (ja)	2020-01-30
AU2017387791A1 (en)	2019-06-13
WO2018125538A1 (en)	2018-07-05
AU2017387791B2 (en)	2022-04-28
MX2019007714A (es)	2019-09-09
EP3562541B1 (en)	2021-07-14
US11471677B2 (en)	2022-10-18
EP3562541A1 (en)	2019-11-06
US20200023183A1 (en)	2020-01-23

Legal Events

Date

Code

Title

Description

2019-06-24

PA0105

International application

Patent event date: 20190624

Patent event code: PA01051R01D

Comment text: International Patent Application

2019-08-28

PG1501

Laying open of application

2021-01-09

PC1203

Withdrawal of no request for examination

Publication	Publication Date	Title
US20230001202A1 (en)	2023-01-05	Article and method for treating diabetic peripheral neuropathy
Lee et al.	2019	Mechano-neuromodulation of autonomic pelvic nerve for underactive bladder: A triboelectric neurostimulator integrated with flexible neural clip interface
Xu et al.	2021	Effects of electrical stimulation on skin surface
JP5108787B2 (ja)	2012-12-26	埋め込まれた受動導体を介して電流を体組織へルーティングする方法
JP4879754B2 (ja)	2012-02-22	移植された非活性導電体を介して、身体組織に電流を搬送する方法
US8560075B2 (en)	2013-10-15	Apparatus and method for the treatment of headache
AU2013368951B2 (en)	2017-09-21	Method and apparatus to increase tactile sensitivity and proprioception in humans
US20240325728A1 (en)	2024-10-03	Electrodes for neuromodulation
US20090326602A1 (en)	2009-12-31	Treatment of indications using electrical stimulation
US20150257970A1 (en)	2015-09-17	Device and method for reducing pain
CN108136177A (zh)	2018-06-08	用于对脊髓进行经皮电刺激的电极阵列及其用途
Micera et al.	2010	Wearable neural prostheses
US20230248962A1 (en)	2023-08-10	System, method, and apparatus for applying bilateral transcutaneous electrical stimulation
Greig et al.	2022	Electrical stimulation for wound healing: opportunities for E-textiles
CN108136176A (zh)	2018-06-08	制造用于脊髓的经皮电刺激的电极阵列的方法
US20130253412A1 (en)	2013-09-26	Roller-ball applicator for transdermal iontophoretic delivery
CN110404164A (zh)	2019-11-05	脊髓闭环性电刺激系统
Naito et al.	1998	Inhibitory projections from pronator teres to biceps brachii motoneurones in human
KR101242553B1 (ko)	2013-03-25	전기침 플랫폼
WO2021080977A1 (en)	2021-04-29	Method and apparatus for controlling multi-site neurostimulation
Torregrosa et al.	2016	Bioelectric medicine and devices for the treatment of spinal cord injury
Cooper et al.	1989	Review articles: Minimizing fatigue for functional electrical stimulation of muscle
RAGNARSSON	1994	The physiologic aspects and clinical application of functional electrical stimulation in rehabilitation
CN121606810A (zh)	2026-03-06	多模式上肢矫正锻炼器
Guo et al.	2025	Therapeutic Electrical Stimulation

KR20190100205A - 당뇨성 말초 신경병증 치료용 물품 - Google Patents

Info

Links

Images

Classifications

Landscapes

Applications Claiming Priority (3)

Publications (1)

Family

ID=60888650

Family Applications (1)

Country Status (7)

Cited By (1)

Families Citing this family (32)

Family Cites Families (30)

Cited By (1)

Also Published As

Similar Documents

Legal Events